Craft

General Biologicals Corporation

Stock Price

NT$18.5

2024-10-29

Market Capitalization

NT$1.1 B

2024-10-29

Revenue

NT$251.9 M

FY, 2024

General Biologicals Corporation Summary

Company Summary

Overview
General Biologicals Corporation (GBC, 普生股份有限公司) is a biotechnology company that researches, develops, produces, and distributes in-vitro diagnostics (IVD) solutions and technologies. It provides diagnostic reagents, testing systems, and molecular diagnostic solutions for disease detection. The company serves the laboratory diagnostic, pharma, healthcare, and consumer industries.
Type
Public
Status
Active
Founded
1984
HQ
Hsinchu, TW | view all locations
Website
https://www.gbc.com.tw/en/home/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • TC Lin
  • Frank Lin
  • Cherie Lin

    Cherie Lin, VP, Healthcare

    • Jen-Leigh Wu, Board Member

      LocationsView all

      2 locations detected

      • Hsinchu, Hsinchu City HQ

        Taiwan

        Hsinchu Science Park, No. 6, Innovation 1st Road

      • 高雄市

        Taiwan

        63 號 2 樓

      General Biologicals Corporation Financials

      Summary Financials

      Revenue (H1, 2025)
      NT$110.7M
      Gross profit (H1, 2025)
      NT$35.9M
      Net income (H1, 2025)
      (NT$129.3M)
      Cash (H1, 2025)
      NT$195.8M
      EBIT (H1, 2025)
      (NT$112.0M)
      Enterprise value
      $3.4B

      Footer menu